25
Views
0
CrossRef citations to date
0
Altmetric
CLINICAL TRIAL REPORT

Acupuncture as Add-on Therapy to SSRIs Can Improve Outcomes of Treatment for Anxious Depression: Subgroup Analysis of the AcuSDep Trial

, , , , , , , , , , , , , , , , & show all
Pages 1049-1064 | Received 23 Oct 2023, Accepted 22 Apr 2024, Published online: 18 May 2024

References

  • Rush AJ. The varied clinical presentations of major depressive disorder. J Clin Psychiatry. 2007;68(Suppl 8):4–10.
  • Gaspersz R, Lamers F, Wittenberg G, et al. The role of anxious distress in immune dysregulation in patients with major depressive disorder. Transl Psychiatry. 2017;7(12):1268. doi:10.1038/s41398-017-0016-3
  • Gaspersz R, Nawijn L, Lamers F, Penninx BWJH. Patients with anxious depression: overview of prevalence, pathophysiology and impact on course and treatment outcome. Curr Opin Psychiatry. 2018;31(1):17–25. doi:10.1097/YCO.0000000000000376
  • Chan HN, Rush AJ, Nierenberg AA, et al. Correlates and outcomes of depressed out-patients with greater and fewer anxious symptoms: a CO-MED report. Int J Neuropsychopharmacol. 2012;15(10):1387–1399. doi:10.1017/S1461145711001660
  • Fava M, Alpert JE, Carmin CN, et al. Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D. Psychol Med. 2004;34(7):1299–1308. doi:10.1017/s0033291704002612
  • Wiethoff K, Bauer M, Baghai TC, et al. Prevalence and treatment outcome in anxious versus nonanxious depression: results from the German Algorithm Project. J Clin Psychiatry. 2010;71(8):1047–1054. doi:10.4088/JCP.09m05650blu
  • Fava M, Rush AJ, Alpert JE, et al. Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. Am J Psychiatry. 2008;165(3):342–351. doi:10.1176/appi.ajp.2007.06111868
  • Seo HJ, Song HR, Jeong S, et al. Does comorbid subthreshold anxiety predict treatment response in depression? Results from a naturalistic cohort study (the CRESCEND study). J Affect Disord. 2014;152–154:352–359. doi:10.1016/j.jad.2013.09.037
  • Wu Z, Chen J, Yuan C, et al. Difference in remission in a Chinese population with anxious versus nonanxious treatment-resistant depression: a report of OPERATION study. J Affect Disord. 2013;150(3):834–839. doi:10.1016/j.jad.2013.03.012
  • Farabaugh A, Alpert J, Wisniewski SR, et al. Cognitive therapy for anxious depression in STAR(*) D: what have we learned? J Affect Disord. 2012;142(1–3):213–218. doi:10.1016/j.jad.2012.04.029
  • Coplan JD, Aaronson CJ, Panthangi V, Kim Y. Treating comorbid anxiety and depression: psychosocial and pharmacological approaches. World J Psychiatry. 2015;5:366–378. doi:10.5498/wjp.v5.i4.366
  • Wang C, Zhou Y, Zheng W, et al. Association between depression subtypes and response to repeated-dose intravenous ketamine. Acta Psychiatr Scand. 2019;140:446–457. doi:10.1111/acps.13096
  • Wright BM, Eiland EH, Lorenz R. Augmentation with atypical antipsychotics for depression: a review of evidence-based support from the medical literature. Pharmacotherapy. 2013;33(3):344–359. doi:10.1002/phar.1204
  • Ionescu DF, Niciu MJ, Mathews DC, Richards EM, Zarate CA. Neurobiology of anxious depression: a review. Depress Anxiety. 2013;30(4):374–385. doi:10.1002/da.22095
  • Maria I, Danielle D, Rayus K, Kai B, Ryan S. The unique face of comorbid anxiety and depression: increased interoceptive fearfulness and reactivity. Front Behav Neurosci. 2023;16:1083357. doi:10.3389/fnbeh.2022.1083357
  • Armour M, Smith CA, Wang LQ, et al. Acupuncture for depression: a systematic review and meta-analysis. J Clin Med. 2019;8:1140. doi:10.3390/jcm8081140
  • Smith CA, Armour M, Lee MS, Wang LQ, Hay PJ. Acupuncture for depression. Cochrane Database Syst Rev. 2018;3:CD004046. doi:10.1002/14651858.CD004046.pub4
  • Zhao BC, Li ZG, Wang YZ, et al. Manual or electroacupuncture as an add-on therapy to SSRIs for depression: a randomized controlled trial. J Psychiatr Res. 2019;114:24–33. doi:10.1016/j.jpsychires.2019.04.005
  • Zhao BC, Li ZG, Wang YZ, et al. Can acupuncture combined with SSRIs improve clinical symptoms and quality of life in patients with depression? Secondary outcomes of a pragmatic randomized controlled trial. Complement Ther Med. 2019;45:295–302. doi:10.1016/j.ctim.2019.03.015
  • Weller J, Tzaridis T, Mack F, et al. Health-related quality of life and neurocognitive functioning with lomustine-temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, Phase 3 trial. Lancet Oncol. 2019;20:1444–1453. doi:10.1016/S1470-2045(19)30502-9
  • Ionescu DF, Niciu MJ, Henter ID, Zarate CA. Defining anxious depression: a review of the literature. CNS Spectr. 2013;18(5):252–260. doi:10.1017/S1092852913000114
  • Rao S, Zisook S. Anxious depression: clinical features and treatment. Curr Psychiatry Rep. 2009;11(6):429–436. doi:10.1007/s11920-009-0065-2
  • Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56–62. doi:10.1136/jnnp.23.1.56
  • Stassen HH, Delini-Stula A, Angst J. Time course of improvement under antidepressant treatment: a survival-analytical approach. Eur Neuropsychopharmacol. 1993;3(2):127–135. doi:10.1016/0924-977x(93)90264-m
  • Zung WW. A self-rating depression scale. Arch Gen Psychiatry. 1965;12(1):63–70. doi:10.1001/archpsyc.1965.01720310065008
  • Guy W. ECDEU Assessment Manual for Psychopharmacology Revised. Rockville: National Institute of Mental Health; 1976.
  • Asberg M, Cronholm B, Sjöqvist F, Tuck D. Correlation of subjective side effects with plasma concentrations of nortriptyline. Br Med J. 1970;4:18–21. doi:10.1136/bmj.4.5726.18
  • World Health Organization. WHOQOL-BREF: Introduction, Administration, Scoring and Generic Version of the Assessment: Field Trial Version. Geneva: World Health Organization; 1996.
  • Cohen J. Statistical Power Analysis for the Behavioural Sciences. 2nd ed. London: Routledge; 1988.
  • Fava M, Rush AJ, Alpert JE, et al. What clinical and symptom features and comorbid disorders characterize outpatients with anxious major depressive disorder: a replication and extension. Can J Psychiatry. 2006;51(13):823–835. doi:10.1177/070674370605101304
  • Sun X, Ioannidis JPA, Agoritsas T, Alba AC, Guyatt G. How to use a subgroup analysis: users’ guide to the medical literature. JAMA. 2014;311:405–411. doi:10.1001/jama.2013.285063
  • Wang R, Lagakos SW, Ware JH, Hunter DJ, Drazen JM. Statistics in medicine--reporting of subgroup analyses in clinical trials. N Engl J Med. 2007;357:2189–2194. doi:10.1056/NEJMsr077003
  • Yang XY, Yang NB, Huang FF, Ren S, Li ZJ. Effectiveness of acupuncture on anxiety disorder: a systematic review and meta-analysis of randomised controlled trials. Ann Gen Psychiatry. 2021;20:9. doi:10.1186/s12991-021-00327-5
  • Amorim D, Amado J, Brito I, et al. Acupuncture and electroacupuncture for anxiety disorders: a systematic review of the clinical research. Complement Ther Clin Pract. 2018;31:31–37. doi:10.1016/j.ctcp.2018.01.008
  • Duan DM, Tu Y, Chen LP, Wu ZJ. Efficacy evaluation for depression with somatic symptoms treated by electroacupuncture combined with Fluoxetine. J Tradit Chin Med. 2009;29(3):167–173. doi:10.1016/s0254-6272(09)60057-1
  • Zhang WJ, Yang XB, Zhong BL. Combination of acupuncture and fluoxetine for depression: a randomized, double-blind, sham-controlled trial. J Altern Complement Med. 2009;15(8):837–844. doi:10.1089/acm.2008.0607
  • Yuan Q, Li JN, Liu B, Wu ZF, Jin R. Effect of Jin-3-needling therapy on plasma corticosteroid, adrenocorticotrophic hormone and platelet 5-HT levels in patients with generalized anxiety disorder. Chin J Integr Med. 2007;13(4):264–268. doi:10.1007/s11655-007-0264-9
  • Liu Y, Feng H, Mo Y, et al. Effect of soothing-liver and nourishing-heart acupuncture on early selective serotonin reuptake inhibitor treatment onset for depressive disorder and related indicators of neuroimmunology: a randomized controlled clinical trial. J Tradit Chin Med. 2015;35(5):507–513. doi:10.1016/s0254-6272(15)30132-1
  • Fei Y, Guo Z, Chai Q, Yang C, Liu J. Methodology key points and quality control in randomized controlled trials of needling. Modern Chin Clin Med. 2013;20:27–30.
  • Zhang G, Zhang C, Tan H, et al. Systematic review of acupuncture placebo devices with a focus on the credibility of blinding of healthy participants and/or acupuncturists. Acupunct Med. 2018;36:204–214. doi:10.1136/acupmed-2017-011484
  • Xin LM, Chen L, Ji ZP, et al. Risk factors for anxiety in major depressive disorder patients. Clin Psychopharmacol Neurosci. 2015;13(3):263–268. doi:10.9758/cpn.2015.13.3.263
  • Nelson JC. Anxiety does not predict response to duloxetine in major depression: results of a pooled analysis of individual patient data from 11 placebo-controlled trials. Depress Anxiety. 2010;27(1):12–18. doi:10.1002/da.20632
  • Zhang Y, Qu SS, Zhang JP, et al. Rapid onset of the effects of combined selective serotonin reuptake inhibitors and electroacupuncture on primary depression: a meta-analysis. J Altern Complement Med. 2016;22(1):1–8. doi:10.1089/acm.2015.0114
  • Menke A, Lehrieder D, Fietz J, et al. Childhood trauma dependent anxious depression sensitizes HPA axis function. Psychoneuroendocrinology. 2018;98:22–29. doi:10.1016/j.psyneuen.2018.07.025
  • Andreescu C, Wu M, Butters MA, Figurski J, Reynolds CF, Aizenstein HJ. The default mode network in late-life anxious depression. Am J Geriatr Psychiatry. 2011;19(11):980–983. doi:10.1097/JGP.0b013e318227f4f9
  • Liu CH, Ma X, Song LP, et al. Abnormal spontaneous neural activity in the anterior insular and anterior cingulate cortices in anxious depression. Behav Brain Res. 2015;281:339–347. doi:10.1016/j.bbr.2014.11.047
  • Pannekoek JN, van der Werff SJ, van Tol MJ, Veltman DJ, Aleman A, Zitman FG. Investigating distinct and common abnormalities of resting-state functional connectivity in depression, anxiety, and their comorbid states. Eur Neuropsychopharmacol. 2015;25(11):1933–1942. doi:10.1016/j.euroneuro.2015.08.002
  • Qiao J, Tao S, Wang X, et al. Brain functional abnormalities in the amygdala subregions is associated with anxious depression. J Affect Disord. 2020;276:653–659. doi:10.1016/j.jad.2020.06.077
  • Deng D, Liao H, Duan G, et al. Modulation of the default mode network in first-episode, drug-naïve major depressive disorder via acupuncture at Baihui (GV20) acupoint. Front Hum Neurosci. 2016;10:230. doi:10.3389/fnhum.2016.00230
  • Wang X, Wang Z, Liu J, et al. Repeated acupuncture treatments modulate amygdala resting state functional connectivity of depressive patients. Neuroimage Clin. 2016;12:746–752. doi:10.1016/j.nicl.2016.07.011
  • Wang Z, Wang X, Liu J, et al. Acupuncture treatment modulates the corticostriatal reward circuitry in major depressive disorder. J Psychiatr Res. 2017;84:18–26. doi:10.1016/j.jpsychires.2016.09.014